The Femtech World Awards 2025, delivered in partnership with headline sponsor Planned Parenthood, celebrates the brightest lights in women’s health innovation. We will be celebrating some...
By Morgan Rose, Chief Science Officer, Ema
A new set of guidelines has been developed to assist with the diagnosis and expert management of serious blood cancers in pregnancy, with an Australian working...
A new study suggests that midlife nonheterosexual women are more likely to remain sexually active and less likely to report pain during sexual activity than heterosexual...
A new review of clinical studies has found that endometriosis is associated with upper gastrointestinal (GI) problems and higher healthcare usage. Previous research has indicated that...
A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage...
A novel ultrasound technology is being utilised to accurately measure and monitor breast density, and in the process improve early detection rates and assess how at...
An integrated polygenic risk score (iPRS) for personalised breast cancer risk assessment has been launched which reports five-year and lifetime breast cancer risk, offers individuals who...
A new study describes an innovative method of analysing mammograms that significantly improves the accuracy of predicting the risk of breast cancer development over the following...
An MRI-based imaging technique can predict the response of ovarian cancer tumours to treatment and rapidly reveals how well treatment is working in patient-derived cell models....
